BJL
CRDF icon

Brighton Jones LLC’s Cardiff Oncology CRDF Stock Holding History

Brighton Jones LLC’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.5K Buy
+16,956
New +$34.8K ﹤0.01% 1182
2025
Q4 		– Sell
-16,506
Closed -$34K – 234
2025
Q3 		$34K Buy
16,506
+3
+0% +$8 ﹤0.01% 1013
2025
Q2 		$52K Buy
16,503
+3
+0% +$9 ﹤0.01% 905
2025
Q1 		$51.8K Buy
+16,500
New +$65.2K ﹤0.01% 689

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return

Brighton Jones LLC's CRDF Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 16,956 shares worth $27.5K. The stake represents ﹤0.01% of the portfolio and ranks #1182 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in CRDF as recently as Q3 2025.

Brighton Jones LLC first reported a position in CRDF in Q1 2025 and has held it in 4 quarters since. The position peaked at $52K in Q2 2025. 117 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Brighton Jones LLC held 16,956 shares of Cardiff Oncology worth $27.5K as of Q1 2026.
  • Cardiff Oncology was a new Brighton Jones LLC position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Brighton Jones LLC's portfolio in Q1 2026, its #1182 holding.
  • Brighton Jones LLC first reported a position in Cardiff Oncology in Q1 2025 and has held it in 4 quarters since.
  • Brighton Jones LLC's Cardiff Oncology position peaked at $52K in Q2 2025.
  • 117 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.